中国实用神经疾病杂志
中國實用神經疾病雜誌
중국실용신경질병잡지
Chinese Journal of Practical Nervous Diseases
2015年
21期
6-8
,共3页
丹栀逍遥散%艾司西酞普兰%缺血性脑卒中%抑郁症
丹梔逍遙散%艾司西酞普蘭%缺血性腦卒中%抑鬱癥
단치소요산%애사서태보란%결혈성뇌졸중%억욱증
Danzhi Xiaoyao power%Escitalopram%Ischemic stroke%Depression
目的:探讨丹栀逍遥散联合艾司西酞普兰片治疗缺血性脑卒中后抑郁症对患者总体康复水平的影响。方法将68例缺血性脑卒中后抑郁症患者按入院顺序随机分为观察组和对照组。对照组予以艾司西酞普兰片口服,初始剂量5 mg/d,连服3d,3d后改为10mg/d口服;观察组在此基础上加用丹栀逍遥散加减治疗,水煎服,3次/d,100mL/次,2组疗程均为8周。观察2组患者的HAMD评分、Hcy水平、血脂水平及不良反应。结果治疗后4周及治疗后6周,2组HAMD评分比较差异有统计学意义(P<0.05),观察组较对照组HAMA评分减少显著;观察组治疗后 Hcy水平较治疗前显著下降,差异有统计学意义(P<0.05),对照组治疗后 Hcy无显著变化。对照组治疗后血脂水平较治疗前无明显变化,观察组治疗后TC、TG较治疗前下降(P<0.05);观察组治疗后H‐DLC较治疗前增高(P<0.05)。2组不良反应差异无统计学意义。结论丹栀逍遥散联合艾司西酞普兰片治疗缺血性脑卒中后抑郁症对患者总体康复水平有积极的影响。
目的:探討丹梔逍遙散聯閤艾司西酞普蘭片治療缺血性腦卒中後抑鬱癥對患者總體康複水平的影響。方法將68例缺血性腦卒中後抑鬱癥患者按入院順序隨機分為觀察組和對照組。對照組予以艾司西酞普蘭片口服,初始劑量5 mg/d,連服3d,3d後改為10mg/d口服;觀察組在此基礎上加用丹梔逍遙散加減治療,水煎服,3次/d,100mL/次,2組療程均為8週。觀察2組患者的HAMD評分、Hcy水平、血脂水平及不良反應。結果治療後4週及治療後6週,2組HAMD評分比較差異有統計學意義(P<0.05),觀察組較對照組HAMA評分減少顯著;觀察組治療後 Hcy水平較治療前顯著下降,差異有統計學意義(P<0.05),對照組治療後 Hcy無顯著變化。對照組治療後血脂水平較治療前無明顯變化,觀察組治療後TC、TG較治療前下降(P<0.05);觀察組治療後H‐DLC較治療前增高(P<0.05)。2組不良反應差異無統計學意義。結論丹梔逍遙散聯閤艾司西酞普蘭片治療缺血性腦卒中後抑鬱癥對患者總體康複水平有積極的影響。
목적:탐토단치소요산연합애사서태보란편치료결혈성뇌졸중후억욱증대환자총체강복수평적영향。방법장68례결혈성뇌졸중후억욱증환자안입원순서수궤분위관찰조화대조조。대조조여이애사서태보란편구복,초시제량5 mg/d,련복3d,3d후개위10mg/d구복;관찰조재차기출상가용단치소요산가감치료,수전복,3차/d,100mL/차,2조료정균위8주。관찰2조환자적HAMD평분、Hcy수평、혈지수평급불량반응。결과치료후4주급치료후6주,2조HAMD평분비교차이유통계학의의(P<0.05),관찰조교대조조HAMA평분감소현저;관찰조치료후 Hcy수평교치료전현저하강,차이유통계학의의(P<0.05),대조조치료후 Hcy무현저변화。대조조치료후혈지수평교치료전무명현변화,관찰조치료후TC、TG교치료전하강(P<0.05);관찰조치료후H‐DLC교치료전증고(P<0.05)。2조불량반응차이무통계학의의。결론단치소요산연합애사서태보란편치료결혈성뇌졸중후억욱증대환자총체강복수평유적겁적영향。
Objective To study the effect of Danzhi Xiaoyao power combined with escitalopram on the overall rehabilitation in patients with depression after ischemic stroke.Methods 68 cases with depression after ischemic stroke were randomly divid‐ed into observation group and control group according to the admission order.Patients in control group received escitalopram tablets orally with the initial dose of 5mg/d for 3 days and then 10mg/d instead.Based on the control group ,patients in obser‐vation group received modified therapy of Danzhi Xiaoyao power orally with the volume of 100mL three times daily for 8 weeks treatment. We observed the HAMD scores ,Hcy levels ,lipid levels and adverse reactions of the two groups.Results After 4‐week and 6‐week treatment ,the HAMD scores in two groups showed statistical difference (P<0.05) ,which were remarkably lower in observation group than that in control group. Compared with pre‐treatment ,Hcy levels decreased significantly after treatment in observation group with a statistical difference (P<0.05) ,which had no significant difference in control group. In terms of liquid levels ,there was no significant change in the control group after treatment ,while the TC and TG levels de‐creased significantly and H‐DLC level increased significantly in the observation group after treatment (P<0.05). In addition , there was no significant difference between the two groups as for adverse reactions.Conclusion The therapy of Danzhi Xiaoyao power combined with escitalopram has positive effect on the general recovery in patients with depression after ischemic stroke.